Search results
Results from the WOW.Com Content Network
For example, venlafaxine works alongside its primary metabolite O-desmethylvenlafaxine to strongly inhibit serotonin and norepinephrine reuptake in the brain. The evidence also suggests that dopamine and norepinephrine behave in a co-transportational manner, due to the inactivation of dopamine by norepinephrine reuptake in the frontal cortex ...
This is a list of psychiatric medications used by psychiatrists and other physicians to treat mental illness or distress. The list is ordered alphabetically according to the condition or conditions, then by the generic name of each medication. The list is not exhaustive and not all drugs are used regularly in all countries.
The International Consensus Statement on ADHD shows that the results from systematic reviews, meta-analyses and large scale studies are clear: methylphenidate is safe and among the most efficacious drugs in all of medicine; treatment in the long-term substantially reduces accidental injuries, traumatic brain injury, substance abuse, cigarette ...
A 2024 study investigating the prevalence of persistent post-treatment genital numbness among sexual and gender minority youth found 13.2% of SSRI users between the ages 15 and 29 reporting the symptom compared to 0.9% who had used other medications. [77] Reports of PSSD have occurred with almost every SSRI (dapoxetine is an exception). [64]
This is an alphabetical list of psychiatric medications used by psychiatrists and other physicians to treat mental illness or distress. The list is not exhaustive. All mentioned drugs here are generic names. Not all drugs listed are used regularly in all countries.
A limitation of certain medications used to improve motivation, like psychostimulants, is development of tolerance to their effects. [ 18 ] [ 19 ] Rapid acute tolerance to amphetamines is believed to be responsible for the dissociation between their relatively short durations of action (~4 hours for main desired effects) and their much longer ...
The review authors noted that research into the potential brain benefits of GLP-1 medications needs more research but are optimistic about the future of these drugs in how they may boost brain health.
Pentobarbital can reduce intracranial pressure in Reye's syndrome, treat traumatic brain injury and induce coma in cerebral ischemia patients. [8] Pentobarbital-induced coma has been advocated in patients with acute liver failure refractory to mannitol. [9] Pentobarbital is also used as a veterinary anesthetic agent. [10]